Use of Omics Methods to Classify Variations of Uncertain Significance and Improve Diagnosis of Neurogenetic Diseases

Many neurological disorders show a strong genetic basis, from hereditary diseases caused by a single mutation in a given gene, to diseases caused by combinations of strong genetic risk factors. However, even after the sequencing of the appropriate genes, a large proportion of patients remains undiagnosed, either because there is no candidate mutation observed, or in case of identification of a candidate mutation with insufficient knowledge to consider it as pathogenic or not. The aim of this project is to identify the cause of neurogenetic diseases in patients in situations of diagnostic wandering or dead ends by proposing the analysis of RNA and/or proteins from different tissues.

NCT Number	NCT06955624
Lead Sponsor	University Hospital, Rouen Collaborators: University Hospital, Lille, Groupe Hospitalier Pitie-Salpetriere
Conditions	Neurogenetic Diseases
Enrollment	95 participants
Start Date	2025-01-15
Primary Completion	2030-01-15 (estimated)
Study Completion	2031-01-15 (estimated)
Updated on ClinicalTrials.gov	2025-05-02